While both medications may cause appetite suppression and cardiovascular effects , their combination necessitates careful monitoring of potential side effects, including gastrointestinal symptoms and risks of hypoglycemia
Earlier this month, he announced that he co-owns the peptide company Crush Research
In addition to efficacy, these trials should assess long-term safety, quality of life, and cost-effectiveness
For many patients, success means being able to do the things they love whether thats walking without pain or keeping up with their kids, said Dr
Conclusions The study findings indicate that the use of GLP-1 receptor agonists is not associated with an increased risk of self-harm, suicidal ideation, and suicide as compared to DPP-4 and SGLT-2 inhibitors among T2D patients